Heru Inc., a Miami FL-based company developer of wearable AI-powered vision diagnostics and augmentation software, raised $30m in Series A funding.
The round was led by D1 Capital Partners with participation from SoftBank Ventures Opportunity Fund, Maurice R. Ferre, M.D., Frederic H. Moll, M.D., Krillion Ventures, and a consortium of investors.
The company intends to use the funds to advance the development of its eye diagnostic and vision correction (augmentation) technology platform.
Led by founder and CEO Mohamed Abou Shousha, M.D., Ph.D., Heru has developed patented autonomous AI-powered vision diagnostics and augmentation software for use on commercially available AR/VR devices. This technology can autonomously diagnose vision defects and customize individual vision augmentation based on the user’s unique vision defects.
Originated as a spinout from Bascom Palmer Eye Institute, Heru holds 24 patents on vision augmentation and wearable diagnostics to date. The patented diagnostics software is registered with the U.S. Food & Drug Administration (FDA) as a Class I exempt device. It is compatible with off-the-shelf AR/VR headsets, including Microsoft and Magic Leap devices.
The company is also developing vision augmentation software that is designed to correct the user’s vision defects in real time using AI.
FinSMEs
20/05/2021